Collapsin response mediator protein-2: An emerging pathologic feature and therapeutic target for neurodisease indications

Molecular Neurobiology

Volumn 43, Issue 3, 2011, Pages 180-191

  Hensley, Kenneth ^a   Venkova, Kalina ^a   Christov, Alexandar ^a   Gunning, William ^a   Park, Joshua ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Alzheimer; CRMP2; Epilepsy; Lacosamide; Lanthionine; Schizophrenia; Tianeptine

Indexed keywords

COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; FLUOXETINE; HARKOSERIDE; ION CHANNEL; LANTHIONINE; SEROTONIN UPTAKE INHIBITOR; TIANEPTINE;

ALZHEIMER DISEASE; ARTICLE; CELL STRUCTURE; DEPRESSION; DRUG MECHANISM; DRUG PROTEIN BINDING; EPILEPSY; HUMAN; NEURITE; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SCHIZOPHRENIA;

EID: 79958282898     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-011-8166-4     Document Type: Article

References (73)

1. Y Goshima F Nakamura P Strittmatter SM Strittmatter 1995 Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33 Nature 376 509 514 7637782 10.1038/376509a0 1:CAS:528:DyaK2MXnsVCrsL0%3D
2. N Inagaki K Chihara N Arimura C Menager Y Kawano N Matsuo T Nishimura M Amano K Kaibuchi 2001 CRMP-2 induces axons in cultured hippocampal neurons Nat. Neurosci. 4 781 782 11477421 10.1038/90476 1:CAS:528:DC%2BD3MXlslSjs7g%3D (Pubitemid 32702507)
3. AR Cole A Knebel NA Morrice LA Robertson AJ Irving CN Connolly C Sutherland 2004 GSK-3 phosphorylation of the Alzheimer epitope within collapsing response mediator proteins regulates axon elongation in primary neurons J. Biol. Chem. 279 50176 40180 15466863 10.1074/jbc.C400412200 1:CAS:528: DC%2BD2cXhtVWjs7jI (Pubitemid 39577830)
4. T Yoshimura Y Kawano N Arimura S Kawabata A Kikuchi K Kaibuchi 2005 GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity Cell 120 137 149 15652488 10.1016/j.cell.2004.11.012 1:CAS:528:DC%2BD2MXot1CgsQ%3D%3D (Pubitemid 40094609)
5. RC Deo EF Schmidt A Elhabazi H Togashi SK Burley SM Strittmatter 2004 Structural bases for CRMP function in plexin-dependent semaphoring 3A signaling EMBO J. 23 9 22 14685275 10.1038/sj.emboj.7600021 1:CAS:528:DC%2BD2cXhtVeqtLk%3D (Pubitemid 38165743)
6. E Charrier S Riebel V Rogemond M Aguera N Thomasset J Honnorat 2003 Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders Mol. Neurobiol. 203 51 63 10.1385/MN:28:1:51 (Pubitemid 38156435)
7. TT Quach A-M Duchemin V Rogemond M Aguera J Honnorat M-F Belin PE Kolattukudy 2004 Involvement of collapsing response mediator proteins in the neurite extension induced by neurotrophins in dorsal root ganglion neurons Mol. Cell. Neurosci. 25 433 443 15033171 10.1016/j.mcn.2003.11.006 1:CAS:528:DC%2BD2cXitFKmsbg%3D (Pubitemid 38366408)
8. N Arimura N Inagaki K Chihara C Menager N Nakamura A Iwamatsu 2000 Phosphorylation of CRMP-2 by Rho kinase: evidence for two separate signaling pathways for growth cone collapse J. Biol. Chem. 275 23,973 23,980 10.1074/jbc.M001032200 1:CAS:528:DC%2BD3cXls12ls7k%3D (Pubitemid 30624686)
9. N Arimura C Meneger Y Fukata K Kaibuchi 2004 Role of CRMP-2 in neuronal polarity J. Neurobiol. 58 34 47 14598368 10.1002/neu.10269 1:CAS:528: DC%2BD2cXlvVemsw%3D%3D (Pubitemid 37543336)
10. Y Kawano T Yoshimura D Tsuboi S Kawabata T Kaneko-Kawano H Shirataki T Takenawa K Kaibuchi 2005 CRMP-2 is involved in kinesin-1-dependent transport of the Swa-1/WAVE1 complex and axon formation Mol. Cell. Biol. 25 9920 9935 16260607 10.1128/MCB.25.22.9920-9935.2005 1:CAS:528:DC%2BD2MXht1altrjN (Pubitemid 41572740)
11. S Patrakitkomjorn D Kobayashi T Morikawa MM Wilson N Tsubota A Irie T Ozawa M Aoki N Arimura K Kaibuchi H Sava N Araki 2008 Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associated protein, CRMP-2 J. Biol. Chem. 283 9399 9414 18218617 10.1074/jbc.M708206200 1:CAS:528:DC%2BD1cXjslyqs7g%3D
12. JM Brittain AD Piekarz Y Wang T Kondo TR Cummins R Khanna 2009 An atypical role for collapsing response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels J. Biol. Chem. 284 31375 31390 19755421 10.1074/jbc.M109.009951 1:CAS:528:DC%2BD1MXhtlCjsr%2FO
13. K Hensley A Christov S Kamat XC Zhang KW Jackson S Snow J Post 2010 Proteomic identification of binding partners for the brain metabolite lanthionine ketimine (LK) and documentation of LK effects on microglia and motoneuron cell cultures J. Neurosci. 30 2979 2988 20181595 10.1523/JNEUROSCI. 5247-09.2010 1:CAS:528:DC%2BC3cXivVSnu70%3D
14. CC Chu JJ Wang KT Chen JP Shieh LK Wang HA Shui ST Ho 2010 Neurotrophic effects of tianeptine on hippocampal neurons: a proteomic approach J. Proteome Res. 9 936 944 20000655 10.1021/pr900799b 1:CAS:528:DC%2BC3cXjt1OqtQ%3D%3D
15. V Rogemond C Auger P Giraudon M Bechi N Auvergnon M-F Belin J Honnorat M Moradi-Ameli 2008 Processing and nuclear localization of CRMP2 during brain development induce neurite outgrowth inhibition J. Biol. Chem. 283 14751 14761 18332147 10.1074/jbc.M708480200 1:CAS:528:DC%2BD1cXlvFyjtrY%3D
16. V Majava N Loytynoja W-Q Chen G Lubec P Kursula 2008 Crystal and solution structure, stability, and post-translational modifications of collapsing response mediator protein-2 FEBS J. 275 4583 4596 18699782 10.1111/j.1742-4658. 2008.06601.x 1:CAS:528:DC%2BD1cXhtFChtLrF
17. JX Zhu HA Doyle MJ Mamula DW Aswad 2006 Protein repair in the brain, proteomic analysis of endogenous substrates for protein l-isoaspartyl methyltransferase in mouse brain J. Biol. Chem. 281 33802 33813 16959769 10.1074/jbc.M606958200 1:CAS:528:DC%2BD28XhtFegsbvK (Pubitemid 46036757)
18. RN Cole GW Hart 2001 Cytosolic O-glycosylation is abundant in nerve terminals J. Neurochem. 79 1080 1089 11739622 10.1046/j.1471-4159.2001.00655.x 1:CAS:528:DC%2BD3MXptFOhtro%3D (Pubitemid 33117089)
19. JB Owen F Di Domenico R Sultana M Perluigi C Cini WM Pierce DA Butterfield 2009 Proteomics-determined differences in the concanavalin-a- fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD J. Proteome Res. 8 471 482 19072283 10.1021/pr800667a 1:CAS:528:DC%2BD1cXhsV2hur3O
20. TT Reed WM Pierce WR Markesbery DA Butterfield 2009 Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD Br Res 1274 66 76 10.1016/j.brainres.2009.04.009 1:CAS:528:DC%2BD1MXmtlOqsb8%3D
21. YC Chae S Lee K Heo SH Ha Y Jung JH Kim Y Ihara PG Suh SH Ryu 2009 Collapsin response mediator protein-2 regulates neurite formation by modulating tubulin GTPase activity Cell. Signal. 21 1818 1826 19666111 10.1016/j.cellsig. 2009.07.017 1:CAS:528:DC%2BD1MXht1GgtrvJ
22. Y Uchida T Ohshima Y Sasaki H Suzuki S Yanai N Yamashita F Nakamura K Takei Y Ihara K Mikoshiba P Kolattukudy J Honnorat Y Goshima 2005 Semaphorin3A Signaling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease Genes Cells 10 165 179 15676027 10.1111/j.1365-2443.2005. 00827.x 1:CAS:528:DC%2BD2MXhs1emtLY%3D (Pubitemid 40287519)
23. MP Soutar P Thornhill AR Cole C Sutherland 2009 Increased CRMP2 phosphorylation is observed in Alzheimer's disease: does this tell us anything about disease development? Curr Alz Res 6 269 278 10.2174/156720509788486572 1:CAS:528:DC%2BD1MXnsFWktbg%3D
24. T Li C Hawkes HY Qureshi S Kar HK Paudel 2006 Cyclin-dependent protein kinase 5 primes microtubule-associated protein Tau site-specifically for glycogen synthase kinase 3beta Biochemistry 14 3134 3145 10.1021/bi051635j (Pubitemid 43376332)
25. MG Lykissas AK Batistatou A Konstantinos KA Charalabopoulos AE Beris 2007 The role of neurotrophins in axon guidance, growth and regeneration Curr Neurovas Res 4 143 151 10.2174/156720207780637216 1:CAS:528:DC%2BD2sXmtVGlsbk%3D (Pubitemid 46708904)
26. N Arimura T Kimura S Nakamuta S Taya Y Funahashi A Hattori A Shimada C Menager S Kawabata K Jujii A Iwamatsu RA Segal M Fukuda K Kaibuchi 2009 Anterograde transport of TrkB in axons is mediated by direct interaction with Slp1 and Rab27 Dev. Cell 15 675 686 10.1016/j.devcel.2009.03.005
27. A Pollitt RH Insall 2009 WASP and SCAR/WAVE proteins: the drivers of actin assembly J. Cell Sci. 122 2575 2578 19625501 10.1242/jcs.023879 1:CAS:528:DC%2BD1MXhtVGhsL7E
28. T Nishimura Y Fukata K Kato T Yamaguchi Y Matsuura H Kamiguchi K Kaibuchi 2003 CRMP-2 regulates polarized numb-mediated endocytosis for axon growth Nat. Cell Biol. 5 819 826 12942088 10.1038/ncb1039 1:CAS:528:DC%2BD3sXmvVWlurw%3D (Pubitemid 37087170)
29. J Rahajeng SS Giridharan N Naslavsky S Caplan 2010 Collapsin response mediator protein-2 (CRMP2) regulates trafficking by linking endocytic regulatory proteins to dynein motors J. Biol. Chem. 285 31918 31922 20801876 10.1074/jbc.C110.166066 1:CAS:528:DC%2BC3cXht1GqtbrL
30. Price DL, Thinakaran G, Borchelt DR, et al. (1998) Neuropathology of Alzheimer's disease and animal models, in The neuropathology of dementing disorders, Markesbery, WR, ed., Edward Arnold, London, UK, pp. 121-141
31. SD Hanks DG Flood 1991 Region-specific stability of dendritic extent in normal human aging and regression in Alzheimer's disease. I. CA1 of hippocampus Br Res 54 63 82 10.1016/0006-8993(91)90493-F
32. SA Scott 1993 Dendritic atrophy and remodeling of amygdaloid neurons in Alzheimer's disease Dementia 4 264 271 7505158 1:STN:280:DyaK2c%2FosVSqtw%3D%3D
33. C Duyckaerts B Delatour M-C Potier 2009 Classification and basic pathology of Alzheimer's disease Acta Neuropathol. 118 5 36 19381658 10.1007/s00401-009-0532-1 1:CAS:528:DC%2BD1MXmt1ahu70%3D
34. T Arendt 2009 Synaptic degeneration in Alzheimer's disease Acta Neuropathol. 118 167 179 19390859 10.1007/s00401-009-0536-x
35. SW Scheff DA Price FA Schmitt ST DeKosky EJ Mufson 2007 Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment Neurology 68 1501 1508 17470753 10.1212/01.wnl.0000260698.46517.8f 1:STN:280:DC%2BD2s3mtFersg%3D%3D (Pubitemid 46685921)
36. S Oddo A Caccamo JD Shepherd MP Murphy TE Golde R Kayad R Metherate MP Mattson Y Akbari FM LaFerla 2003 Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction Nature 39 409 421 1:CAS:528:DC%2BD3sXmsFOksro%3D (Pubitemid 36937044)
37. H Yoshida A Watanabe Y Ihara 1998 Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease J. Biol. Chem. 273 9761 9768 9545313 10.1074/jbc.273.16.9761 1:CAS:528:DyaK1cXivVOrt7g%3D (Pubitemid 28183069)
38. AR Cole W Noble L van Aalten F Plattner R Meimaridou D Hogan M Taylor J LaFrancois F Gunn-Moore A Verkhratski S Oddo F LaFerla KP Giese KT Dineley K Duff JC Richardson SD Yan DP Hanger SM Allan C Sutherland 2007 Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression J. Neurochem. 103 1132 1144 17683481 10.1111/j.1471-4159.2007.04829.x 1:CAS:528:DC%2BD2sXhtlSitLfP (Pubitemid 47568734)
39. Y Gu N Hamajima Y Ihara 2000 Tangle-associated collapsin response mediator protein-2 (CRMP-2) is highly phosphorylated on Thr-509, Ser-518, Ser-522 Biochemistry 39 4267 4275 10757975 10.1021/bi992323h 1:CAS:528:DC%2BD3cXhvVyktrY%3D (Pubitemid 30212642)
40. Q Wang RL Woltier PJ Cimino C Pan KS Montine J Zhang TF Montine 2005 Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament Tau binding protein FASEB J. 19 869 871 15746184 10.1096/fj.04-2370com 1:CAS:528:DC%2BD2MXktVKmtLs%3D (Pubitemid 40069914)
41. K Takata Y Kitamura Y Nakata Y Matsuoka H Taomimoto T Taniguchi S Shimohama 2009 Involvement of WAVE accumulation in Aβ/APP pathology-dependent tangle modification in Alzheimer's disease Am. J. Pathol. 175 17 24 19497998 10.2353/ajpath.2009.080908 1:CAS:528:DC%2BD1MXos1Crtbs%3D
42. CD Kamat S Gadal MC Mhatre KS Williamson QN Pye K Hensley 2009 Antioxidants in central nervous system diseases: preclinical promise and translational challenges J Alzheimer's Dis 15 473 493
43. A Martinez M Portero-Otin R Pamplona I Ferrer 2010 Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates Brain Pathol. 20 281 297 19725834 10.1111/j.1750-3639.2009.00326.x 1:CAS:528:DC%2BC3cXjs1Ggsbo%3D
44. M Pawlik DA Otero M Park WH Fischer E Levy T Saitoh 2007 Proteins that bind to the RERMS region of beta amyloid precursor protein Biochem. Biophys. Res. Commun. 355 907 912 17335780 10.1016/j.bbrc.2007.02.047 1:CAS:528:DC%2BD2sXivVags78%3D (Pubitemid 46366914)
45. K Nakata H Ujike A Sakai M Takaki T Imamura Y Tanaka S Kuroda 2003 The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia Biol. Psychiatry 53 571 576 12679234 10.1016/S0006-3223(02)01729-8 1:CAS:528:DC%2BD3sXisV2ns78%3D (Pubitemid 36385058)
46. T Koide B Aleksic Y Ito H Usui A Yoshima T Inada M Suzuki R Hashimoto M Takeda N Iwata N Ozaki 2010 A Two-stage case-control association study of the dihydropyrimidinase-like 2 gene (DPYSL2) with schizophrenia in Japanese subjects J. Hum. Genet. 55 469 472 20414250 10.1038/jhg.2010.38 1:CAS:528: DC%2BC3cXpt1Cku7s%3D
47. MD Fallin VK Lasseter D Avramopoulos KK Nicodemus PS Wolyniec JA McGrath G Steel G Nestadt KY Liang RL Huganir D Valle AE Pulver 2005 Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios Am. J. Hum. Genet. 77 918 936 16380905 10.1086/497703 1:CAS:528:DC%2BD2MXht1ygtLbL (Pubitemid 41698514)
48. D Martins de Souza E Dias-Neto A Schmitt P Falkai P Gormanns G MacCarrone CW Turck WF Gattaz 2010 Proteome analysis of schizophrenia brain tissue World J. Biol. Psychiatry 11 110 120 20109112 10.3109/15622970903490626
49. NL Johnston-Wilson CD Sims JP Hofmann L Anderson AD Shore EF Torrey RH Yolken 2000 Disease-specific alterations in frontal cortex brain proteins in schizophrenia, biopolar disorder, and major depressive disorder Mol. Psychiatry 5 142 149 10822341 10.1038/sj.mp.4000696 1:CAS:528:DC%2BD3cXlslartrg%3D (Pubitemid 30229428)
50. M Arai M Itokawa 2010 A hard road in psychiatric genetics: schizophrenia and DPYSL2 J. Hum. Genet. 55 397 399 20520616 10.1038/jhg.2010.66
51. C Bergson R Levenson PS Goldman-Rakic MS Lidow 2003 Dopanine receptor-interacting proteins: the Ca2+ connection in dopamine signaling Trends Pharmacol. Sci. 24 486 492 12967774 10.1016/S0165-6147(03)00232-3 1:CAS:528:DC%2BD3sXntVGrs70%3D (Pubitemid 37088174)
52. L Bojarski K Debowska U Wojda 2010 In vitro findings of alterations in intracellular calcium homeostasis in schizophrenia Prog Neuro psychopharmacol Biol 34 1367 1374 10.1016/j.pnpbp.2010.08.020 1:CAS:528:DC%2BC3cXhsV2jtrjN
53. Y Kodama Y Murakumo M Ichihara K Kawai Y Shimono M Takahashi 2004 Induction of CRMP-2 by GDNF and analysis of the CRMP-2 promoter region Biochem. Biophys. Res. Commun. 320 108 115 15207709 10.1016/j.bbrc.2004.05.139 1:CAS:528:DC%2BD2cXltVKgsLg%3D (Pubitemid 38781790)
54. F Demotes-Mainard P Galley G Manciet G Vinson C Salvadori 1998 Pharmacokinetics of the antidepressant tianeptine at steady state in the elderly J. Clin. Pharmacol. 31 174 178
55. SH Preskorn 2004 Tianeptine: a facilitator of the reuptake of serotonin and norepinephrine as an antidepressant? J. Psychiatr. Pract. 20 323 330 10.1097/00131746-200409000-00006 (Pubitemid 39299045)
56. S Kasper JP Olie 2002 A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression Eur. Psychiatry 17 Suppl 3 331 340 15177089 10.1016/S0924-9338(02)00651-X (Pubitemid 34839396)
57. TM Sobow M Maczkiewicz I Kloszewska 2001 Tianeptine versus fluoxetin in the treatment of depression complicating Alzheimer's disease Int. J. Geriatr. Psychiatry 16 1108 1109 11746660 10.1002/gps.457 1:STN:280: DC%2BD3Mnps1Onsg%3D%3D (Pubitemid 33089277)
58. R Jaffard E Mocaer JC Poignant J Micheau A Marighetto M Meunier D Beracochea 1991 Effects of tianeptine on spontaneous alternation, simple and concurrent spatial discrimination learning and on alcohol-induced alternation deficits in mice Behav. Pharmacol. 1 37 46
59. AM Magarinos A Deslandes BS McEwen 1999 Effects of antidepressants and benzodiazepine treatments on the dendritic structure of CA2 pyramidal neurons after chronic stress Eur. J. Pharmacol. 371 113 122 10357248 10.1016/S0014-2999(99)00163-6 1:CAS:528:DyaK1MXjtlCksL8%3D (Pubitemid 29216993)
60. A Kelemen P Halász 2010 Lacosamide for the prevention of partial onset seizures in epileptic adults Neuropsychiatr Dis Treat 2010 465 471 10.2147/NDT.S7967
61. B Beyreuther J Freitag C Heers N Krebsfanger U Scharfenecker T Stohr 2007 Lacosamide: a review of preclinical properties CNS Drug Rev. 13 21 42 17461888 10.1111/j.1527-3458.2007.00001.x 1:CAS:528:DC%2BD2sXmtlSltbk%3D (Pubitemid 46697839)
62. LA Bee AH Dickenson 2009 Effects of lacosamide, a novel sodium channel modulator, on dorsal horn neuronal responses in a rat model of neuropathy Neuropharm 57 472 479 10.1016/j.neuropharm.2009.06.021 1:CAS:528: DC%2BD1MXhtVeis7jF
63. GA Higgins N Brevsse E Undzys C Kuo N Joharchi DR Derksen T Xin M Isaac M Slassi 2009 The anti-epileptic drug lacosamide (vimpat) has anxiolytic property in rodents Eur. J. Pharmacol. 624 1 9 19818346 10.1016/j.ejphar.2009.09.050 1:CAS:528:DC%2BD1MXhtlyhtbnP
64. D Cavallini G Ricci S Dupre L Pecci M Costa RM Matarese B Pensa A Antonuci SP Solinas M Fontana 1991 Sulfur-containing cyclic ketimines and imino acids a novel family of endogenous products in search for a role Eur. J. Biochem. 202 217 223 1761027 10.1111/j.1432-1033.1991.tb16365.x 1:CAS:528:DyaK38Xjs1eisA%3D%3D
65. AJ Cooper MW Anders 1990 Glutamine transaminase K and cysteine conjugate-lyase Ann. NY Acad. Sci. 585 118 127 2192607 10.1111/j.1749-6632.1990. tb28048.x 1:CAS:528:DyaK3cXksFCksbY%3D (Pubitemid 20175892)
66. AJL Cooper 2004 The role of glutamine transaminase K (GTK) in sulfur and alpha-keto acid metabolism in the brain, and in the possible bioactivation of neurotoxicants Neurochem. Int. 44 557 577 15016471 10.1016/j.neuint.2003.12.002 1:CAS:528:DC%2BD2cXhvFSlsr4%3D (Pubitemid 38324610)
67. K Hensley K Venkova A Christov 2010 Emerging biological importance of central nervous system lanthionines Molecules 15 5581 5594 20714314 10.3390/molecules15085581 1:CAS:528:DC%2BC3cXhtVGnsLfO
68. Hensley, K. Lanthionine-related compounds for the treatment of inflammatory diseases. US Patent No. 7,683,055. Issued 3/23/2010
69. G Ricci L Vesci M nardini A Arduini S Storto N Rosato D Cavallini 1989 Detection of 2H-1, 4-thiazine-5, 6-dihydro-3, 5-dicarboxylic acid (lanthionine ketimine) in the bovine brain by a fluorometric assay Biochim. Biophys. Acta 990 211 215 2917179 1:CAS:528:DyaL1MXhtFWitr4%3D (Pubitemid 19055414)
70. M Chritin M Savasta G Besson 2006 Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis Amyotroph. Lateral Scler. 7 32 37 16546757 10.1080/14660820510012022 1:CAS:528:DC%2BD28XisVaqu74%3D
71. Z Zhang V Majava A Greffier RL Hayes P Kursula KK Wang 2009 Collapsin response mediator protein-2 is a calmodulin-binding protein Cell. Mol. Life Sci. 66 526 536 19151921 10.1007/s00018-008-8362-1 1:CAS:528:DC%2BD1MXht1Gnsb0%3D
72. Neuron. In: Wikipedia, the free encyclopedia. Available at: http://en.wikipedia.org/w/index.php?title=Neuron&oldid=362961603
73. JF Margiotta MJ Howard 1994 Eye extract factors promote the expression of acetylcholine sensitivity in chick dorsal root ganglion neurons Dev. Biol. 163 188 201 8174774 10.1006/dbio.1994.1135 1:CAS:528:DyaK2cXkslyktrc%3D (Pubitemid 24188883)